Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials!!

Clinical Trial 10190

Prairie Village, KS 66206

Study Summary:

Long term safety study to look at safety and tolerability of adding a new study medication while continuing to take prescribed anti-depressant; wanting subjects who are partial responders to current SSRI anti-depressant medication.

Qualified Participants Must:

• Be between 18 and 35 years of ager
• Be currently taking prescribed SSRI medication for depression for at least the past 6 weeks
• Have a lack of response of current depression symptoms to 2 or more therapeutic courses of anti-depressant medication treatment
• Have symptoms that should include pervasive depressed mood or loss of interest that occurs for at least 2 weeks along with other core symptomes of fatigue, difficulty concentrating, feelings of worthlessness, sleep and appetite disturbances
• Have not participated in a study within the past 30 days
• Not have anxiety disorder, PTSD, obsessive compulsive disorder as a concurrent Diagnosis
• Not have bipolar, schizophrenia or other psychotic disorders
• Have ho history of ECT within past year
• Not have seizure disorders
• Be taking birth control
• If alcoholic, must be clean and sober for at least one year

Qualified Participants May Receive:

If you qualify and sign an informed consent form for a study, you may receive reimbursement for travel and inconvenience for every visit you complete.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.